One small study about the course of PRL in prediabetic patients with polycystic ovary syndrome (PCOS) and hyperprolactinemia showed that metformin led to an improvement in insulin resistance, which was not accompanied by a decrease in PRL. Here, PRL is linked to polycystic ovary syndrome.